Eyegate Pharmaceuticals' Series D - II Round

Eyegate Pharmaceuticals raised a round of funding on January 10, 2011.

EyeGate Pharma, a privately held specialty pharmaceutical company developing a non-invasive ocular drug delivery platform and ocular therapeutics designed to address two major issues in ophthalmic med…

Articles about Eyegate Pharmaceuticals' Series D - II Round: